Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (51-60 of 304) with videos related to

Pageof 31
Sort By:
Journal of Neurochemistry|July 3, 2019
Parkinson's disease biomarkers based on α-synucleinMuneera Fayyad, Safa Salim, Nour Majbour, et al.
Brain : a Journal of Neurology|December 10, 2015
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodiesAnne Stuendl, Marcel Kunadt, Niels Kruse, et al.
Molecular and Cellular Neurosciences|June 6, 2022
The relevance of synuclein autoantibodies as a biomarker for Parkinson's diseasePretty Garg, Fabian Maass, Sivaraj M Sundaram, et al.
FEBS Open Bio|March 20, 2020
Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuICViktoria C Ruf, Song Shi, Felix Schmidt, et al.
Neurobiology of Disease|January 12, 2023
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-upIlham Yahya Abdi, Michael Bartl, Mohammed Dakna, et al.
Dementia and Geriatric Cognitive Disorders|December 8, 2010
Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasiasMirko Bibl, Brit Mollenhauer, Piotr Lewczuk, et al.
Neuroscience Letters|November 15, 2012
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjectsBrit Mollenhauer, Ellen Trautmann, Peggy Taylor, et al.
Journal of Parkinson'S Disease|November 1, 2021
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Journal of Clinical Laboratory Analysis|July 20, 2012
Plasma amyloid-beta peptides in acute cerebral ischemia: a pilot studyMirko Bibl, Volker Welge, Holger Schmidt, et al.
Dementia and Geriatric Cognitive Disorders|October 28, 2006
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Peter Brechlin, Petra Steinacker, et al.
Pageof 31

Showing results (51-60 of 304) with videos related to

Sort By:
Pageof 31
Journal of Neurochemistry|July 3, 2019
Parkinson's disease biomarkers based on α-synucleinMuneera Fayyad, Safa Salim, Nour Majbour, et al.
Brain : a Journal of Neurology|December 10, 2015
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodiesAnne Stuendl, Marcel Kunadt, Niels Kruse, et al.
Molecular and Cellular Neurosciences|June 6, 2022
The relevance of synuclein autoantibodies as a biomarker for Parkinson's diseasePretty Garg, Fabian Maass, Sivaraj M Sundaram, et al.
FEBS Open Bio|March 20, 2020
Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuICViktoria C Ruf, Song Shi, Felix Schmidt, et al.
Neurobiology of Disease|January 12, 2023
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-upIlham Yahya Abdi, Michael Bartl, Mohammed Dakna, et al.
Dementia and Geriatric Cognitive Disorders|December 8, 2010
Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasiasMirko Bibl, Brit Mollenhauer, Piotr Lewczuk, et al.
Neuroscience Letters|November 15, 2012
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjectsBrit Mollenhauer, Ellen Trautmann, Peggy Taylor, et al.
Journal of Parkinson'S Disease|November 1, 2021
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Journal of Clinical Laboratory Analysis|July 20, 2012
Plasma amyloid-beta peptides in acute cerebral ischemia: a pilot studyMirko Bibl, Volker Welge, Holger Schmidt, et al.
Dementia and Geriatric Cognitive Disorders|October 28, 2006
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Peter Brechlin, Petra Steinacker, et al.
Pageof 31